A method for collecting cancer-incidence data in a rural town is described. A mail survey, prompted and conducted by concerned citizens, was utilized. When analyzed in light of local mortality data and national cancer incidence and mortality rates, the data collected in such a survey seem reasonably accurate and complete. The numbers of observed and expected incident cases, as well as the numbers of observed and expected deaths, correlated quite closely for most sites. Excesses of incident cases were observed for seven of 11 sex-specific sites, but only for melanoma and lymphoma among women were the excesses statistically significant. Provided that community support is substantial, which is necessary to maximize accuracy and completeness, this method of collecting cancer-incidence data may be useful in rural areas of states without a statewide registry.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/08858199409528302 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cancer incidence and competing mortality risk following 15 presenting symptoms in primary care: a population-based cohort study using electronic healthcare records.
BMJ Oncol
November 2024
Department of Behavioural Science and Health, Institute of Epidemiology and Healthcare, University College London, London, UK.
Objectives: Assessment of age, sex and smoking-specific risk of cancer diagnosis and non-cancer mortality following primary care consultation for 15 new-onset symptoms.
Methods And Analysis: Data on patients aged 30-99 in 2007-2017 were extracted from a UK primary care database (CPRD Gold), comprising a randomly selected reference group and a symptomatic cohort of patients presenting with one of 15 new onset symptoms (abdominal pain, abdominal bloating, rectal bleed, change in bowel habit, dyspepsia, dysphagia, dyspnoea, haemoptysis, haematuria, fatigue, night sweats, weight loss, jaundice, breast lump and post-menopausal bleed).Time-to-event models were used to estimate outcome-specific hazards for site-specific cancer diagnosis and non-cancer mortality and to estimate cumulative incidence up to 12 months following index consultation.
Novel machine learning algorithm in risk prediction model for pan-cancer risk: application in a large prospective cohort.
BMJ Oncol
July 2024
National Institute for Data Science in Health and Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Objective: To develop and validate machine-learning models that predict the risk of pan-cancer incidence using demographic, questionnaire and routine health check-up data in a large Asian population.
Methods And Analysis: This study is a prospective cohort study including 433 549 participants from the prospective MJ cohort including a male cohort (n=208 599) and a female cohort (n=224 950).
Results: During an 8-year median follow-up, 5143 cancers occurred in males and 4764 in females.
Implications of hormonal carcinogenesis for transgender and gender-diverse people undergoing gender-affirming hormone therapy: an up-to-date review.
BMJ Oncol
May 2024
Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Transgender and gender-diverse (TGD) individuals face an elevated risk of cancer in comparison with the general population. This increased risk is primarily attributed to an imbalanced exposure to modifiable risk factors and a limited adherence to cancer screening programmes, stemming from historical social and economic marginalisation. Consequently, these factors contribute to poorer clinical outcomes in terms of cancer diagnosis and mortality.
View Article and Find Full Text PDFTemporal trends of liver cancer burden, comparative analysis of risk factors and trend forecasts to 2024 in China, USA, the Republic of Korea, and Mongolia: an analysis based on multiple data sources from Global Burden of Disease 2019, the Global Cancer Observatory, and Cancer Incidence in Five Continents.
J Glob Health
January 2025
School of Health Economics and Management, Nanjing University of Chinese Medicine, Nanjing, China.
Background: Liver cancer represents a significant burden of disease globally, with variations in liver cancer status among countries. In this study, we aimed to evaluate the epidemiological burden of liver cancer in four representative countries - China, the USA, the Republic of Korea, and Mongolia - and cover the highest number of incidence cases, the highest prevalence rates and the burden in developed countries. In addition, we intended to predict the trends in liver cancer in these countries over the next six years.
View Article and Find Full Text PDFBackground: Esophageal and gastric cancer were among the top 10 most common cancers worldwide. In addition, sex-specific differences were observed in the incidence. Due to their anatomic proximity, the 2 cancers have both different but also shared risk factors and epidemiological features.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!